Brazilian Research In Intensive Care Network
11
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
45.5%
5 terminated/withdrawn out of 11 trials
50.0%
-36.5% vs industry average
73%
8 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
Role: collaborator
Adherence to Low Tidal Volume in the Transition to Spontaneous Ventilation in Patients With Acute Respiratory Failure
Role: collaborator
COVID-19 Antithrombotic Rivaroxaban Evaluation
Role: collaborator
Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19
Role: collaborator
Quality of Life and Long-term Outcomes After Hospitalization for COVID-19
Role: collaborator
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
Role: collaborator
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)
Role: collaborator
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
Role: collaborator
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
Role: collaborator
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Role: collaborator
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
Role: collaborator
All 11 trials loaded